about
Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum ComplexesA novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivityA genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegiaBisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cellsEffect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesisPhenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profileGlutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapyStructure-function studies of the RNA polymerase II elongation complexSoluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug designGenome-wide requirements for resistance to functionally distinct DNA-damaging agents.Targeting DNA Replication Stress for Cancer TherapyC-Jun N-terminal kinase signalling pathway in response to cisplatinNew Therapeutic Concept of NAD Redox Balance for Cisplatin NephrotoxicityDrug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the LiteratureHigh Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerMitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer ChemotherapyHuman Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical CancerBeyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid TumorsMechanisms of Cisplatin nephrotoxicityThe path for metal complexes to a DNA targetPermeation, regulation and control of expression of TRP channels by trace metal ionsMitochondrial DNA damage and its consequences for mitochondrial gene expressionStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketBypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase etaSimilar Biological Activities of Two Isostructural Ruthenium and Osmium Complexescis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospectsCrystal Structures of Cisplatin Bound to a Human Copper ChaperoneX-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adductStructure of duplex DNA containing the cisplatin 1,2-{Pt(NH3)2}2+-d(GpG) cross-link at 1.77Å resolutionConsequences of Cisplatin Binding on Nucleosome Structure and DynamicsStructural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapyThe crystal structure analysis of the relative binding of cisplatin and carboplatin in a mixture with histidine in a protein studied at 100 and 300 K with repeated X-ray irradiationStructural and mechanistic studies of polymerase bypass of phenanthriplatin DNA damageCopper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxificationThe X-ray structure of the complex formed in the reaction between oxaliplatin and lysozymeThe X-ray structure of the primary adducts formed in the reaction between cisplatin and cytochrome cOxaliplatin vs. cisplatin: competition experiments on their binding to lysozymeCisplatin encapsulation within a ferritin nanocage: a high-resolution crystallographic studyAurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosisThe Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
P2860
Q24289008-91E9180E-9E0F-42D8-A89C-CF8C38D76303Q24313389-71E13BD1-9DA1-457B-B432-1C6B02A8DA49Q24338151-DC0D7791-4FE0-4EC4-AC2F-6939E4F30BECQ24596235-066B55EA-F067-406E-8D63-36C8E6F48624Q24613748-6B0ED35C-92C4-40E6-BECF-66AD9874F6D5Q24625759-206E9658-DCD8-4DA7-9C84-6314FF19E505Q24629542-1723F3A6-5B50-45A7-9178-5CBB8BAF1514Q24644966-F107AE31-6DC7-43C5-A46F-7500FCE42AB7Q24646512-77EBA5C6-A092-4C7D-BAD4-4D8F08F59BAFQ24815105-31D25170-59EE-4E09-A42D-CEF6B031E5AAQ26739923-10A71098-FDDB-475D-802C-C4144D4B4D36Q26745463-38C7DF92-7F4B-4A58-BE13-5CF3410FE4D4Q26765483-91072AD1-0B83-4BEE-86A3-1F7684DE003CQ26766244-16DCEFE3-472F-4EDE-BA6B-B19FE1A92156Q26774902-BE0EC05A-6894-42B9-9220-36604451E885Q26797353-F700A236-2010-4C06-A836-FA25B392B046Q26799484-F10888B8-E1A8-43F7-B2B9-95CB396B4F9DQ26852274-B97A8E6B-4C92-4950-B742-B4514B17021CQ26996320-9A29EC04-DE08-4D88-A533-91F1C96F0340Q26999667-F961A642-27AB-4190-A12A-FD3C4F95173DQ26999694-6696EA2B-09EE-4B02-BE24-2BF4365C6493Q27001150-52348D8A-058F-4BF2-8DF2-DA3F0B18F471Q27015050-FDC8A2DD-C4AE-4FDE-8400-D8B40900DAC6Q27648988-B9DA8E4D-9D4F-4BEF-996F-1F2430D21B60Q27650404-5F8C7008-4765-4A02-AA74-ACBF631EC012Q27650949-91A7E320-C7F2-4E7D-9E93-44A50056E56DQ27657700-BCB05D66-1AAD-4B40-9A1C-A07E51FD52C6Q27661393-5924F5D6-2A0F-4348-88EE-672779ADD2BBQ27662176-3A3995C3-4C98-4AD9-A731-3FF9A042D9CAQ27666340-14DBFEAD-7F4F-42C2-98E0-4C846B90D211Q27678933-8BD5AC8D-493B-47E7-A69E-2324A98E2D94Q27683672-D09A4887-7CB1-4969-BD26-4E9FB24CD315Q27684330-B2D1D4BE-D0EC-4ABB-8EE5-8F227F98B4C6Q27684801-90BE0B27-50E7-4CBB-8B15-BDC2F72A2BFCQ27690763-6B76B3A5-F7C8-4CBB-BF15-8073D99ECD86Q27697308-E2989B5C-A285-47F8-B5F6-950F5D215F21Q27700850-B4D79E0B-8BEE-43AD-AF52-CE6C7F74200DQ27704043-CF56E91A-647C-45B3-AC21-7EF585A94FA0Q27853047-1047C4A6-2346-426F-BEEB-3A105487BF41Q28066801-7F73F879-0EFB-4FC9-9A30-7DC6579F1B9B
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cellular processing of platinum anticancer drugs
@ast
Cellular processing of platinum anticancer drugs
@en
type
label
Cellular processing of platinum anticancer drugs
@ast
Cellular processing of platinum anticancer drugs
@en
prefLabel
Cellular processing of platinum anticancer drugs
@ast
Cellular processing of platinum anticancer drugs
@en
P2860
P3181
P356
P1476
Cellular processing of platinum anticancer drugs
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/NRD1691
P407
P577
2005-04-01T00:00:00Z
P6179
1044896419